Omval i danska Lif

Ordförande får sitta kvar ännu ett år i den danska läkemedelsbranschens egen organisation.

By Loth Hammar

April 2, 2009 12:00 AM

Vid Läkemedelsindustriföreningens

årsmöte den 31 mars fick den sittande styrelseordföranden Lone Aagaard, Astrazeneca förnyat förtroende.

De övriga styrelsemedlemmarna

i danska Lif är Jan Iversen, Lundbeck Pharma, Dorthe Mikkelsen, Merck Sharp & Dohme, Tore Wäborg, LEO Pharma, Camilla Sylvest, Novo Nordisk Scandinavia, Ghita Astrup, Nycomed Danmark, Peter Legarth, Schering-Plough och Julie Edwards, GlaxoSmithKline.

{{ comments.count === 1 ? '1 comment' : comments.count > 1 ? '{0} comments'.replace('{0}', comments.count) : 'Write a comment' }}

By submitting the comment you accept the terms. See terms

Good comment behavior

Keep a good tone in your comments, avoid personal attacks and posts of marketing character. Apply only link on your comment if it is relevant to the debate.

Be aware that the debates are moderated by the portal's editorial team.

The comment has been created.

Your comment will not be visible until you activate it. In a few moments you will receive an email where you must click on a link to activate your comment.